报价延迟最少15分钟:2026/10/18 19:14 EDT
常规时段
|
|
|
|
|
||||||||||||
|
|
|
|
|
2.68 
|
|
|
| 价值评估 |
|
盈利(现时/预测)
11.11/--
|
|
企业价值
26.98M
|
| 资产负债 |
|
每股账面净值
1.26
|
| 现金流量 |
|
现金流量率
--
|
| 损益表 |
|
收益
32.00K
|
|
每股收益
--
|
|
同行比较
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
同行比较之报价最少15分钟延迟 (夜盘时段除外)
|
业务概览
|
|||
| Impact BioMedical Inc focuses on the advancement of drug discovery and prevention, inhibition, and treatment of neurological, oncological, and immune-related diseases. The company is also developing open-air defense initiatives, which curbtransmission of air-borne infectious diseases, such as tuberculosis and influenza. Its technologies inlcude Linebacker, Laetose, 3F, and Equivir. |
